CARLOS RAMOS to Cell- and Tissue-Based Therapy
This is a "connection" page, showing publications CARLOS RAMOS has written about Cell- and Tissue-Based Therapy.
Connection Strength
1.137
-
Cellular Immunotherapy in Lymphoma: Beyond CART Cells. Curr Treat Options Oncol. 2020 02 11; 21(3):21.
Score: 0.614
-
Posoleucel, an Allogeneic, Off-the-Shelf Multivirus-Specific T-Cell Therapy, for the Treatment of Refractory Viral Infections in the Post-HCT Setting. Clin Cancer Res. 2023 01 17; 29(2):324-330.
Score: 0.188
-
T-Cell Therapy for Lymphoma Using Nonengineered Multiantigen-Targeted T Cells Is Safe and Produces Durable Clinical Effects. J Clin Oncol. 2021 05 01; 39(13):1415-1425.
Score: 0.164
-
Cancer Immunotherapy Using CAR-T Cells: From the Research Bench to the Assembly Line. Biotechnol J. 2018 Feb; 13(2).
Score: 0.131
-
The safety and clinical effects of administering a multiantigen-targeted T cell therapy to patients with multiple myeloma. Sci Transl Med. 2020 07 29; 12(554).
Score: 0.040